Orchard, Trevor J.

Does diabetes prevention translate into reduced long-term vascular complications of diabetes?

and the DPP Research Group, Nathan, D. M., Bennett, P. H., Crandall, J. P., Edelstein, S. L., Goldberg, R. B., Kahn, S. E., Knowler, W. C., Mather, K. J., Mudaliar, S., et al. (2019) · Diabetologia

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 91

A novel approach to diabetes prevention: Evaluation of the Group Lifestyle Balance program delivered via DVD

Kramer, M. K., Kriska, A. M., Venditti, E. M., Semler, L. N., Miller, R. G., McDonald, T., Siminerio, L. M., & Orchard, T. J. (2010) · Diabetes Research and Clinical Practice

Diabetes Management and EducationDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 90

The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures

Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes

Nunley, K. A., Ryan, C. M., Orchard, T. J., Aizenstein, H. J., Jennings, J. R., Ryan, J., Zgibor, J. C., Boudreau, R. M., Costacou, T., Maynard, J. D., et al. (2015) · Neurology

Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research

Cited by 68

Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: the DCCT/EDIC study

Bebu, I., Braffett, B. H., Orchard, T. J., Lorenzi, G. M., Lachin, J. M., & the DCCT/EDIC Research Group (2019) · Diabetes Care

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 62

Subjective sleep disturbances and glycemic control in adults with long-standing type 1 diabetes: The Pittsburgh’s Epidemiology of Diabetes Complications study

Denic-Roberts, H., Costacou, T., & Orchard, T. J. (2016) · Diabetes Research and Clinical Practice

Sleep and related disordersDiabetes Management and Research

Cited by 51

Improving adherence to a cholesterol-lowering diet: a behavioral intervention study

Burke, L. E., Dunbar-Jacob, J., Orchard, T. J., & Sereika, S. M. (2005) · Patient Education and Counseling

Medication Adherence and ComplianceMobile Health and mHealth Applications

Cited by 46

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29

Optimal blood pressure thresholds for minimal coronary artery disease risk in type 1 diabetes

Guo, J., Brooks, M. M., Muldoon, M. F., Naimi, A. I., Orchard, T. J., & Costacou, T. (2019) · Diabetes Care

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 22

Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program

Goldberg, R. B., Temprosa, M., Mele, L., Orchard, T., Mather, K., Bray, G., Horton, E., Kitabchi, A., Krakoff, J., Marcovina, S., et al. (2016) · Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 22

Control of Lipids at Baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

Pambianco, G., Lombardero, M., Bittner, V., Forker, A., Kennedy, F., Krishnaswami, A., Mooradian, A. D., Pop‐Busui, R., Rana, J. S., Rodriguez, A., et al. (2009) · Preventive Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 8

Use of an electronic health record to identify prevalent and incident cardiovascular disease in type 2 diabetes according to treatment strategy

Korytkowski, M. T., Karslioglu French, E., Brooks, M., DeAlmeida, D., Kanter, J., Lombardero, M., Magaji, V., Orchard, T., & Siminerio, L. (2016) · BMJ Open Diabetes Research & Care

Diabetes Treatment and ManagementMedical Coding and Health Information

Cited by 6